3M Adds New Products to Cavilon Brand Portfolio

  3M Adds New Products to Cavilon Brand Portfolio

  New 3M Cavilon Bathing & Cleansing Wipes and 3M Cavilon 3-in-1 Total Care
                   Cloths Deliver Effective, Efficient Care

Business Wire

ST. PAUL, Minn. -- June 17, 2013

3M Critical & Chronic Care Solutions Division today announced the release of
two new products, 3M™ Cavilon™ Bathing & Cleansing Wipes and 3M™ Cavilon™
3-in-1 Total Care Cloths. The new offerings from 3M help clinicians to address
the needs for efficacy and efficiency across care settings, and join the
trusted line of Cavilon solutions used in incontinence care applications.

A concern for both patients and caregivers, incontinence can lead to the
development of Incontinence-Associated Dermatitis (IAD), which is a well-known
risk factor in the development of pressure ulcers.^1 IAD has been reported to
occur in 42 percent of incontinent hospitalized adults and up to 95 percent of
incontinent patients in the intensive care unit.^1,2 In addition,
approximately 50 percent of nursing home residents live with incontinence on a
daily basis.^3

The new Cavilon products help clinicians adhere to IAD prevention protocols
and simplify care regimens for efficiency. According to recent clinical
consensus^4 use of a soft, disposable cloth is a preferred approach for
incontinence cleansing. In a U.S. comparison study, use of a no-rinse cleanser
saved caregivers valuable time: an average of 9 minutes per episode^5.

Cleansing, Moisturizing, Protecting

Both new Cavilon products combine gentle pH-balanced cleansing and
emollient-based moisturizing ingredients, which help to maintain the skin’s
natural barrier. Cavilon 3-in-1 Total Care Cloths also provide protection from
moisture and irritants through the use of dimethicone, an ingredient
well-documented as an effective protective barrier. New 3M Bathing & Cleansing
Wipes, which are useful for bathing as well as incontinence care, are
compatible with 3M’s protection barrier products, 3M™ Cavilon™ No Sting
Barrier Film and 3M™ Cavilon™ Durable Barrier Cream. Each product is available
in re-sealable 8- and 24-packs.

“Our new products are consistent with the high level of care expected from the
Cavilon brand while addressing our customers’ need for efficient and
convenient solutions,” said Leslie McDonnell, Vice President Global Marketing,
3M Chronic & Critical Care Solutions Division. “With these additions to our
brand portfolio, we continue to expand our full suite of products for best
practice care and improved patient outcomes.”

3M invites professional and non-professional caregivers and patients to visit
www.3M.com/Cavilon for training, information and support. In addition, a
dedicated toll-free helpline, 1-800-228-3957 has been established. For more
information on 3M Critical & Chronic Care Solutions, visit
www.3M.com/SkinHealth.

About 3M Health Care

3M Health Care offers solutions in the medical, oral care, drug delivery, food
safety and health information markets. We have an unparalleled ability to
connect people, insights, science and technology to think beyond today, solve
problems, and make better health possible. Our culture of collaboration
empowers us to discover and deliver practical, proven solutions that enable
our customers to protect and improve the health of people around the world.
Learn more atwww.3mhealthcare.com.

^1Incontinence Associated Dermatitis (IAD): Best Practice for Clinicians.
Wound, Ostomy and Continence Nurses Society, 2011.

^2Peterson KJ, Bliss DZ, Nelson C, Savik K. Practices of nurses and nursing
assistants in preventing incontinence associated dermatitis in
acutely/critically ill patients. Amer J of Crit Care. (Abstract) 2006; 15(3):
325.

^3Bliss, D. Savik, K. & Peterson, K. Continence-evidence-based treatment and
management: Incontinence-Dermatitis in Hospitalized Patients Prevalence.
Evidence-Based Nursing Care and Nurse Education Program. Journal of Wound,
Ostomy and Continence Nursing. 2009; 36(3S): S56.

^4Doughty D, et al. Incontinence – Associated Dermatitis: Consensus
Statements, Evidence – Based Guidelines for Prevention and Treatment, and
Current Challenges. Journal of Wound, Ostomy and Continence Nursing. 2012;
39(3): 303-315.

^5Lewis-Byers K, Thayer D, Kahl A. An evaluation of two incontinence skin care
protocols in a long-term care setting. Ostomy Wound Management. 2005; 48(12):
44-51.

Contact:

3M
Mary Kokkinen, 651-733-8806
mckokkinen@mmm.com
or
Fleishman-Hillard
Heather Sheriff, 612-573-3105
heather.sheriff@fleishman.com